How AI-driven insights from RWD accelerate the diagnosis and treatment of undiagnosed patients: A case study in alpha-1 antitrypsin deficiency
Alpha-1 antitrypsin deficiency (AATD), a rare genetic condition, can cause lung disease in adults with symptoms similar to chronic obstructive
By Christopher Rudolf, Volv Global An AI methodology for finding patients with rare diseases: Volv Global’s inTrigue The Case
Volv, supported by Sanofi, and working with Optimum Patient Care, and collaborating with a specialist Consultant Clinician, is performing research
